TCM Ltd Releases Q1 FY2026-27 Results; Announces AGM Date and Board Decisions

TCM Ltd Releases Q1 FY2026-27 Results; Announces AGM Date and Board Decisions

TCM Ltd Releases Q1 FY2026-27 Results; Announces AGM Date and Board Decisions​

TCM Limited, formerly Travancore Chemical & Mfg. Co. Ltd., announced the outcomes of its Board meeting held on Thursday, August 13, 2026. The company released its Consolidated and Standalone Unaudited Financial Results along with corresponding Limited Review Reports for the quarter ended June 30, 2026.

The results presented insights into the operations across various segments, while the Board addressed several key governance matters, including setting the date for the Annual General Meeting (AGM) and approving crucial annual reports.

Q1 Financial Performance Summary​

The Unaudited Standalone and Consolidated Financial Results reflected the company's performance across its business segments, which include Trading, Manufacturing, Educational, and Real estate.

According to the Statement of Standalone Financial Results for the quarter ended June 30, 2026 (figures in ₹ Lakhs):

ParticularsQuarter Ended 30-Jun-2026Quarter Ended 31-Mar-2026Year Ended 30-Jun-2025
Revenue from operations402.01396.95304.87
Total income419.11425.96321.14
Expenses (Total)540.80553.13N/A

The Consolidated Statement of Profit and Loss for the quarter ended June 30, 2026 showed:

ParticularsQuarter Ended 30-Jun-2026Quarter Ended 31-Mar-2026Year Ended 31-Mar-2026
Total income493.72513.522,070.03
Profit/ (Loss) for the period(160.13)(162.65)(598.71)

Segment Performance Snapshot​

The company's operations are segmented into Trading, Manufacturing, Educational, and Real estate sectors. The segment disclosures provided a breakdown of revenue and results for the quarter ended June 30, 2026:

SegmentRevenueSegment Results (₹ Lakhs)
Trading89.7330.87
Manufacturing308.61(37.22)
Educational59.382.61
Real estate30.2512.54
Total487.978.80

Key Board Decisions and Governance Updates​

During the Board meeting, several key corporate actions were approved and decisions were made:

  • General Meeting: The company's 824 Annual General Meeting was scheduled to be held on Friday, September 25, 2026, through Physical Means.
  • Report Approvals: The Directors Report, Corporate Governance Report, and the Secretarial Audit Report for the Financial Year 2025-2026 were approved by the Board.
  • Corporate Structure: Approval was granted for the closure of the Share Transfer Register and the Register of Shareholders.
  • Director Appointments: The retirement of Directors by rotation was approved. Furthermore, the re-appointment of Independent Directors Mr. Gopalakrishnan Mahesh and Mr. Jose Jacob was recommended for a second term of five years, commencing from September 29, 2026 to September 28, 2031, subject to shareholder approval at the Annual General Meeting.

Stock Price Movement​

TCM Ltd settled at ₹43.05 in the post-market trading on Wednesday, edging higher after closing a gain of 0.12%. The shares traded within an intraday range that stretched between a low of ₹43.00 and a high of ₹43.10.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top